During the past decade, Showa University Hospital conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 28 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 18 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Showa University Hospital" #1 sponsor was "Pfizer" with 10 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Daiichi Sankyo Co., Ltd." with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Showa University Hospital" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Showa University Hospital" are "Breast Cancer" (5 trials), "Coronary Artery Disease" (5 trials), "Ulcerative Colitis" (4 trials), "Systemic Lupus Erythematosus" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Showa University Hospital" in a lesser frequency.

Most popular intervention types in "Showa University Hospital" are "Drug" (41 trials), "Device" (10 trials), "Other" (5 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Abemaciclib" (5 trials), "Paclitaxel" (3 trials), "Baricitinib" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Showa University Hospital" are 55 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Showa University Hospital". undefined are not yet recruiting, 15 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Showa University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Showa University Hospital, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

Showa University Hospital has several departments that took part in Clinical trials: "Showa University Hospital; Breast Surgery" - 3 trials